New Biosimilar Under Review in Top Specialty Pharmacy News

By Davy James, Managing Editor

Catch up with any news you missed this week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]

Related Videos
View All
Related Content

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Experts Review Treatments, Directions in Basal Cell Carcinoma

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Investigational RSV Vaccine Demonstrates 83.7% Efficacy in Clinical Trial

January 26th 2023

Pembrolizumab Plus Chemotherapy Significantly Improves Overall Survival in First-Line Advanced, Unresectable Biliary Tract Cancer

January 26th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.